Related Experiment Video
Updated: Nov 10, 2025
Antimicrobial Peptides Produced by Selective Pressure Incorporation of Non-canonical Amino Acids
Published on: May 4, 2018
Deep Learning for Novel Antimicrobial Peptide Design
Christina Wang1, Sam Garlick2, Mire Zloh1,3
1UCL School of Pharmacy, University College London, London WC1N 1AX, UK.
Abstract:
Antimicrobial resistance is an increasing issue in healthcare as the overuse of antibacterial agents rises during the COVID-19 pandemic. The need for new antibiotics is high, while the arsenal of available agents is decreasing, especially for the treatment of infections by Gram-negative bacteria like Escherichia coli. Antimicrobial peptides (AMPs) are offering a promising route for novel antibiotic development and deep learning techniques can be utilised for successful AMP design. In this study, a long short-term memory (LSTM) generative model and a bidirectional LSTM classification model were constructed to design short novel AMP sequences with potential antibacterial activity against E. coli. Two versions of the generative model and six versions of the classification model were trained and optimised using Bayesian hyperparameter optimisation. These models were used to generate sets of short novel sequences that were classified as antimicrobial or non-antimicrobial. The validation accuracies of the classification models were 81.6-88.9% and the novel AMPs were classified as antimicrobial with accuracies of 70.6-91.7%. Predicted three-dimensional conformations of selected short AMPs exhibited the alpha-helical structure with amphipathic surfaces. This demonstrates that LSTMs are effective tools for generating novel AMPs against targeted bacteria and could be utilised in the search for new antibiotics leads.
Insights
Researchers developed novel antimicrobial peptides (AMPs) using deep learning to combat rising antimicrobial resistance. These artificial intelligence-designed AMPs show promise against Gram-negative bacteria like Escherichia coli.
Area of Science:
- Biotechnology
- Computational Biology
- Infectious Disease
Background:
- Antimicrobial resistance (AMR) is a growing global health threat, exacerbated by increased antibiotic use during the COVID-19 pandemic.
- There is an urgent need for new antibiotics, particularly against Gram-negative pathogens such as Escherichia coli, as existing treatments become less effective.
- Antimicrobial peptides (AMPs) represent a promising avenue for developing novel therapeutic agents.
Purpose of the Study:
- To design short, novel antimicrobial peptide sequences with potential activity against Escherichia coli using deep learning.
- To evaluate the efficacy of long short-term memory (LSTM) generative and bidirectional LSTM classification models for AMP design.
- To explore the potential of artificial intelligence in accelerating the discovery of new antibiotic leads.
Main Methods:
- Construction and optimization of LSTM generative and bidirectional LSTM classification models using Bayesian hyperparameter optimization.
- Generation of novel peptide sequences using the trained models.
- Classification of generated sequences as antimicrobial or non-antimicrobial.
- Analysis of predicted 3D conformations of selected AMPs.
Main Results:
- Classification models achieved validation accuracies ranging from 81.6% to 88.9%.
- Novel AMPs were successfully classified as antimicrobial with accuracies between 70.6% and 91.7%.
- Predicted structures of selected AMPs revealed characteristic alpha-helical and amphipathic properties.
Conclusions:
- Long short-term memory (LSTM) networks are effective tools for generating novel antimicrobial peptides.
- Deep learning approaches can significantly aid in the search for new antibiotic candidates against challenging bacteria like E. coli.
- This study highlights the potential of AI-driven strategies to address the critical challenge of antimicrobial resistance.
